American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C.: American Psychiatric Publishing; 2014.

Amminger, G.P., Schäfer, M.R., Papageorgiou, K., Klier, C.M., Cotton, S.M., Harrigan, S.M., Mackinnon, A., McGorry, P.D., Berger, G.E. (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry; 67(2): 146-54.

Arango, C., Fraguas, D., & Parellada, M. (2013). Differential Neurodevelopmental Trajectories in Patients With Early-Onset Bipolar and Schizophrenia Disorders. Schizophrenia Bulletin, 40(Suppl 2), S138–S146. https://doi.org/10.1093/schbul/sbt198

Arendt, M., Rosenberg, R., Foldager, L., et al. (2005) Cannabis induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510-515.

Arseneault, L., Cannon, M., Poulton, R., Murray, R., & Caspi, A. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Child and adolescent psychiatry, 325, 1212-1213.

Asarnow, J.R. (1994). Annotation: childhood-onset schizophrenia. Journal of Child Psychology and Psychiatry; 35: 1345-71.

Asarnow, R. F., Forsyth, J. K. (2013). Genetics of childhood-onset schizophrenia. Child Adolesc. Psychiatr. Clin. N Am. 22 (4), 675–687. doi: 10.1016/j.chc.2013.06.004

Boeing, L., Murray, V., Pelosi, A., McCabe, R., Blackwood, D., & Wrate, R. (2007). Adolescent-onset psychosis: prevalence, needs and service provision. British journal of Psychiatry, 198, 18-26.

Boonstra, N., Klaassen, R., Wunderink, L. (2014). Vroegtijdige onderkenning van een psychose; meta-analyse naar verband tussen duur van onbehandelde psychose en beloop van negatieve symptomen. Tijdschrift voor psychiatrie; 56(2014)5, 309-318.

Catalan, A., Salazar de Pablo, G., Vaquerizo Serrano, J., Mosillo, P., Baldwin, H., Fernandez-Rivas, A., Moreno, C., Arango, C., Correll, C. U., Bonoldi, I., Fusar-Poli, P. (2021). Annual Research Review: Prevention of psychosis in adolescents – systematic review and meta-analysis of advances in detection, prognosis and intervention. Journal of Child Psychology and Psychiatry; 62 (5): 657-673. https://doi:10.1111/jcpp.13322

Dama, M., Shah, J., Norman, R., Iyer, S., Joober, R., Schmitz, N., Abdel‐Baki, A., & Malla, A. (2019). Short duration of untreated psychosis enhances negative symptom remission in extended early intervention service for psychosis. Acta Psychiatrica Scandinavica, 140(1), 65–76. https://doi.org/10.1111/acps.13033

David, A.S., Malmberg, A., Brandt, L., Allebeck, P., Lewis, G. (1997). IQ and risk for schizophrenia: a population-based cohort study. Psychological Medicine; 27(6): 1311-1323.

Dealberto, M. (2010). Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent and longstanding immigration. Acta Psychiatrica Scandinavica; 121(5), 325-339.

Díaz-Caneja, C. M., Pina-Camacho, L., Rodríguez-Quiroga, A., Fraguas, D., Parellada, M., & Arango, C. (2015). Predictors of outcome in early-onset psychosis: a systematic review. npj Schizophrenia, 1(1), 1–9. https://doi.org/10.1038/npjschz.2014.5

Došen, A., Gardner, W.I., Griffiths, D.M., King, R., & Lapointe, A. (2008). Richtlijnen en principes voor de praktijk: Beoordeling, diagnose, behandeling en bijbehorende ondersteuning voor mensen met verstandelijke beperkingen en probleemgedrag. Nederlandse bewerking: Ad van Gennep. Utrecht: Vilans/LKNG.

Driver, D. I., Gogtay, N., & Rapoport, J. L. (2013). Childhood Onset Schizophrenia and Early Onset Schizophrenia Spectrum Disorders. Child and Adolescent Psychiatric Clinics of North America, 22(4), 539–555. https://doi.org/10.1016/j.chc.2013.04.001

Ferdinand, R.F., Sondeijker, F., van der Ende, J., Selten, J., Huizink, A., & Verhulst, F.C. (2005). Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 100, 612–618.

Fergusson, D.M., Horwood, L.J., & Ridder, E.M. (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction, 100, 354–366.

Foti, D.J., Kotov, R., Guey, L.T., & Bromet, E.J. (2010). Cannabis use and the course of schizophrenia: 10-year followup after first hospitalization. American Journal of Psychiatry, 167(8), 987–993.

Fusar-Poli, P., Tantardini, M., De Simone, S., Ramella-Cravaro, V., Oliver, D., Kingdon, J., Kotlicka-Antczak, M., Valmaggia, L., Lee, J., Millan, M.J., Galderisi, S., Balottin, U., Ricca, V., & McGuire, P. (2017). Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra-high-risk. Eur Psychiatry.,40, 65-75.

Gardner, K. N., Nasrallah, H.A. (2015). Managing first-episode psychosis: an early stage of schizophrenia with distinct treatment needs. Current Psychiatry. 14(5): 32-34, 36-40, 42

Gordon, C.T., Frazier, J.A., McKenna, K., Giedd, J., Zametkin, A., Zahn, T., Hommer, D., Hong W, Kaysen D, Albus KE. (1994). Childhood-onset schizophrenia: an NIMH study in progress. Schizophrenia Bulletin; 20(4): 697-712.

Gordon, C.T., Krasnewich, D., White, B., Lenane, M., Rapoport, J.L. (1994). Brief report: translocation involving chromosomes 1 and 7 in a boy with childhood-onset schizophrenia. Journal of Autism and Developmental Disorders; 24(4): 537-545.

Gurak, K., & Weisman de Mamani, A. (2016). Risk and Protective Factors, Perceptions of Family Environment, Ethnicity, and Schizophrenia Symptoms. The Journal of Nervous and Mental Disease, 204(8), 570–577. https://doi.org/10.1097/nmd.0000000000000558

De Haan, L., Becker, H. (2006). Psychosen. In: Leerboek Psychiatrie, Kinderen en adolescenten. Utrecht: De Tijdstroom.

Henquet, C., Murray, R., Linszen, D., van Os, J. (2005). Envoronment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin; 31(3): 608-612.

Hilker, R., Helenius, D., Fagerlund, B., Skytthe, A., Christensen, K., Werge, T. M., Nordentoft, M., & Glenthøj, B. (2018). Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register. Biological Psychiatry, 83(6), 492–498. https://doi.org/10.1016/j.biopsych.2017.08.017

Horton, L. E., Tarbox, S. I., Olino, T. M., & Haas, G. L. (2015). Trajectories of premorbid childhood and adolescent functioning in schizophrenia-spectrum psychoses: A first-episode study. Psychiatry Research, 227(2–3), 339–346. https://doi.org/10.1016/j.psychres.2015.02.013

Horwood, J., Salvi, G., Thomas, K., et al. (2008) IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. The British Journal of Psychiatry, 193, 185-191

De Jong (2019). Bijzondere ervaringen. Wat zijn dat eigenlijk? Folder Youz.

Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O’Donovan, M., Correll, C. U., Kane, J. M., van Os, J., & Insel, T. R. (2015). Schizophrenia. Nature Reviews Disease Primers, 1(1), 1–23. https://doi.org/10.1038/nrdp.2015.67

Karayiorgou, M., Morris, M.A., Morrow, B., Shprintzen, R.J., Goldberg, R., Borrow, J., Gos, A., Nestadt, G., Wolyniec, P.S., Lasseter, V.K. (1995). Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.Proceedings of the National Academy of Sciences; 92(17): 7612-7616.

Kraan, T., Velthorst, E., Koenders, L., Zwaart, K., Ising, H.K., van den Berg, D., de Haan, L., van der Gaag, M. (2016). Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. Psychol Med.,46(4), 673-81.

Kraan, T., Velthorst, E., Smit, F., de Haan, L., & van der Gaag, M. (2015). Trauma and recent life events in individuals at ultra-high risk for psychosis: review and meta-analysis. Schizophr Res.,161(2-3), 143-9.

Krabbendam, L., van Os, J. (2005). Schizophrenia and urbanicity: a major environmental influence–conditional on genetic risk. Schizophrenia Bulletin; 31(4): 795-799.

Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de ggz. (2005). Multidisciplinaire richtlijn Schizofrenie 2005. Utrecht: Trimbos-instituut (Via www.ggzrichtlijnen.nl)

Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de ggz (2012). Multidisciplinaire richtlijn Schizofrenie. Utrecht: De Tijdstroom.

Lang, B. S., Boumans, C., & Nijman, H. (2020). Is de Korte Schaal voor Negatieve Symptomen een bruikbaar instrument? GZ – Psychologie, 12(1), 16–22. https://doi.org/10.1007/s41480-020-0116-1

Masi, G., Mucci, M., Pari, C. (2006). Children with schizophrenia. Clinical picture and pharmacological treatment. CNS drugs; 20(10): 841-866.

Mastrigt, S. van, Addington, J., Addington, D. (2004). Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology; 39(1): 69-72.

McClellan, J., Breiger, D., McCurry, C., Hlastala, S.A. (2003) Premorbid functioning in early-onset psychotic disorders. Journal of the American Academy of Child and Adolescent Psychiatry; 42(6): 666-672.

Moore, T.H, Zammit, S., Lingford-Hughes, A., Barnes, T.R., Jones, P.B., Burke, M., Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet; 370(9584): 319-328.

Murphy, K.C., Jones, L.A., Owen, M.J. (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry; 56(10): 940-945.

Murray, R. M., Mondelli, V., Stilo, S. A., Trotta, A., Sideli, L., Ajnakina, O., Ferraro, L., Vassos, E., Iyegbe, C., Schoeler, T., Bhattacharyya, S., Marques, T. R., Dazzan, P., Lopez-Morinigo, J., Colizzi, M., O’Connor, J., Falcone, M. A., Quattrone, D., Rodriguez, V., … Di Forti, M. (2020). The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study. Schizophrenia Research, 225, 63–68. https://doi.org/10.1016/j.schres.2020.01.011

NICE (National institute for Health and Clinical Excellence) (2013). Psychosis and Schizophrenia in children and young people. Recognition and Management. Nice Richtlijn CG 155, Londen.

Os, J. van & Kapur, S. (2009) Schizophrenia. The Lancet, 374, 635-645.

Powers, A. R., Addington, J., Perkins, D. O., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., Seidman, L. J., Tsuang, M. T., Walker, E. F., McGlashan, T. H., & Woods, S. W. (2020). Duration of the psychosis prodrome. Schizophrenia Research, 216, 443–449. https://doi.org/10.1016/j.schres.2019.10.051

Qi, R., Palmier‐Claus, J., Simpson, J., Varese, F., & Bentall, R. (2019). Sexual minority status and symptoms of psychosis: The role of bullying, discrimination, social support, and drug use – Findings from the Adult Psychiatric Morbidity Survey 2007. Psychology and Psychotherapy: Theory, Research and Practice, 93(3), 503–519. https://doi.org/10.1111/papt.12242

Raballo, A., Monducci, E., Ferrara, M., Fiori Nastro, P., & Dario, C. (2018). Developmental vulnerability to psychosis: Selective aggregation of basic self-disturbance in early onset schizophrenia. Schizophrenia Research, 201, 367–372. https://doi.org/10.1016/j.schres.2018.05.012

Read, J., van Os, J., Morrison, A.P., Ross, C.A. (2005). Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica; 112(5): 330-350.

Ropcke, B. & Eggers, C. (2005). Early-onset schizophrenia: a 15-year follow-up.
European Child and Adolescent Psychiatry, 14, 341–350.

Russell, A.T., Bott, L., Sammons, C. (1989). The phenomenology of schizophrenia occurring in childhood. Journal of the American Academy of Child and Adolescent Psychiatry; 28(3): 399-407.

Schizofrenie | Cijfers & Context | Oorzaken en gevolgen | Volksgezondheidenzorg.info. (2021). Volksgezondheid en Zorg. https://www.vzinfo.nl/schizofrenie/oorzaken-en-gevolgen

Schneider, M. (2008). Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction Biology; 13(2): 253-263.

Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res. (2014);154:100–106.

Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG,
Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des (2012) 18:351–7.

Selten, J.-P., Laan, W., Kupka, R., Smeets, H., & Os, J. van (2011). Meer kans op depressie en psychose bij allochtonen. Nederlands Tijdschrift voor de Geneeskunde, 155, 1-7.

Sevy, S., Robinson, D.G., Holloway, S., Alvir, J.M., Woerner, M.G., Bilder, R., Goldman, R., Lieberman, J., Kane, J. (2001). Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica; 104(5): 367-374.

Sikich, L. (2013). Diagnosis and Evaluation of Hallucinations and Other Psychotic Symptoms in Children and Adolescents. Child and Adolescent Psychiatric Clinics of North America, 22(4), 655–673. https://doi.org/10.1016/j.chc.2013.06.005

Stafford, M.R., Jackson, H., Mayo-Wilson, E., Morrison, A.P., & Kendall, T. (2013). Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ, 346:f185.

Stentebjerg-Olesen, M., Pagsberg, A. K., Fink-Jensen, A., Correll, C. U., & Jeppesen, P. (2016). Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review. Journal of Child and Adolescent Psychopharmacology, 26(5), 410–427. https://doi.org/10.1089/cap.2015.0097

Stichting PsychoseNet. (2021). Dopamine en psychose: wat is de relatie? PsychoseNet. Https://www.psychosenet.nl/psychose/oorzaken-psychose/dopamine/

Strålin, P., & Hetta, J. (2019). First episode psychosis and comorbid ADHD, autism and intellectual disability. European Psychiatry, 55, 18–22. https://doi.org/10.1016/j.eurpsy.2018.09.007

Van Alphen C., Ammeraal M., Blanke C., Boonstra N., Boumans H., Bruggeman R., et al. (2012). Multidisciplinaire richtlijn schizofrenie. Tweede revisie ed.: De Tijdstroom

Van der Gaag, M., van den Berg, D., & Ising, H. (2019). CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps. Schizophrenia Research, 203, 88-93.

Van der Gaag, M., Nieman, H., Rietdijk, J., Dragt, S., Ising, H.K., Klaassen, R.M.C., et al., (2012).Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: arandomized controlled clinical trial. Schizophr. Bull. 38 (6), 1180–1188.

Veerman, S. (2020). Behandeling van positieve, negatieve en cognitieve symptomen bij therapieresistente schizofrenie. 15. 10-21.

Veling, W., Selten, J-P. Veen, N., Laan, W., Blom, J.D., & Hoek, H.W. (2006). Incidence of schizophrenia among ethnic minorities in the Netherlands: A four-year first-contact study. Schizophrenia Research, 86,189-193.

Velthorst, E., Nieman, D.H., Becker, H.E., van de Fliert, R., Dingemans, P.M., Klaassen, R., de Haan, L., van Amelsvoort, T., Linszen, D.H. (2009). Baseline differences in clinical symptomatology between ultra-high risk subjects with and without a transition to psychosis. Schizophrenia Research; 109(1-3): 60-65.

Vorstman, J.A., Breetvelt, E.J., Hillegers, M.H., Scheepers, F.E. (2015). Psychose: symptomen en stoornissen onderscheiden bij kinderen en adolescenten. Tijdschrift voor psychiatrie 57(2015)12, 928-932

Vyas Shirk, D., & S Janjua, K. (2020). “One in a million”: A case of a very early onset schizophrenia. Case Reports International, 9, 1. https://doi.org/10.5348/100083z06ds2020cr

Wigman, J.T.W., Vollebergh, W.A.M.,Raaijmakers, Q.A.W., Iedema, J., van Dorsselaer, S., Ormel, J., Verhulst, F.C., & van Os, J. (2011). The Structure of The Extended Psychosis Phenotype in Early Adolescence—A Cross-sample Replication. Schizophr Bull., 37(4), 850–860.

Wunderink, L. (z.d.). Spreekuurthuis schizofrenie. Spreekuurthuis. https://spreekuurthuis.nl/themas/schizofrenie/informatie/de_symptomen_van_schizofrenie/affectieve_symptomen (niet langer online)

Wunderink, L., van Bebber, J., Sytema, S., Boonstra, N., Meijer, R. R., & Wigman, J. T. W. (2020). Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy. Schizophrenia Research, 225, 69–76. https://doi.org/10.1016/j.schres.2020.11.046

Zorgstandaard Psychose (2017). Netwerk Kwaliteitsontwikkeling GGZ. Utrecht.